Philip Morris
An Estimate of Adult Mortality in the United States From Passive Smoking
Fields
- Author
- Wells, A.J.
- Type
- PSCI, PUBLICATION SCIENTIFIC
- BIBL, BIBLIOGRAPHY
- CHAR, CHART, GRAPH, TABLE, MAPS
- BIBL, BIBLIOGRAPHY
- Area
- SCIENTIFIC AFFAIRS/BLACK LATERAL OLD S&T
- Document File
- 2023511660/2023512308/Ets: Heart Disease 930900
- Litigation
- Okag/Privilege Withdrawn
- Okag/Produced
- Characteristic
- EXTR, EXTRA
- Site
- R529
- Named Organization
- US Natl Center for Health Statistics
- Author (Organization)
- Environment Intl
- Named Person
- Blot, W.J.
- Brownson, R.C.
- Buffler, P.
- Crofton, J.
- Dalager, N.A.
- Garfinkel, L.
- Geng
- Hirayama, T.
- Hunt, S.C.
- Koo, L.C.
- Lam
- Martin
- Pershagen, G.
- Repace, J.L.
- Reynolds, P.
- Robins, J.
- Samet, J.M.
- Sandler, D.P.
- Trichopoulos, D.
- Wilson, R.W.
- Wu, A.H.
- Brownson, R.C.
- Master ID
- 2023511661/2307
Related Documents:- 2023511661-2307 Environmental Tobacco Smoke and Heart Disease
- 2023511710 the Relationship of Passive Smoking to Various Health Outcomes Among Seventh-Day Adventists in California.
- 2023511714-1718 Passive Smoking and the Risk of Heart Attack or Coronary Death
- 2023511722-1727 Effects of Passive Smoking on Ischemic Heart Disease Mortality of Nonsmokers A Prospective Study
- 2023511728 Erratum
- 2023511729 'effects of Passive Smoking on Ischemic Heart Disease Mortality of Nonsmokers: A Prospective Study'
- 2023511730 the First Author Replies
- 2023511734-1737
- 2023511738-1744 Passive Smoking in Females and Coronary Heart Disease
- 2023511749-1756 Original Contributions Heart Disease Mortality in Nonsmokers Living with Smokers
- 2023511760-1781 Lung Cancer in Japan: Effects of Nutrition and Passive Smoking
- 2023511785-1789 Passive Smoking and Cardiorespiratory Health in A General Population in the West of Scotland
- 2023511790 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511791-1792 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511793-1795 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511800-1802 Public Health Briefs Passive Smoking and 20-Year Cardiovascular Disease Mortality Among Nonsmoking Wives, Evans County, Georgia
- 2023511806-1816 Relationship of Passive Smoking to Risk of Lung Cancer and Other Smoking-Associated Diseases
- 2023511818 Increased Incidence of Heart Attacks in Nonsmoking Women Married to Smokers
- 2023511822-1824 Cvd Epidemiology Newsletter
- 2023511829-1841 Original Contributions Effects of Passive Smoking in the Multiple Risk Factor Intervention Trial
- 2023511842 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511843-1844 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511845 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511846 the Authors Reply
- 2023511849-1853 Smoking As A Risk Factor for Cerebral Ischemia
- 2023511857-1862 Urinary Cotinine Measurement in Patients with Buerger's Disease - Effects of Active and Passive Smoking on the Disease Process
- 2023511882 Editorial Cardiovascular Risks of Environmental Tobacco Smoke
- 2023511883-1887 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511888-1890 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511891-1892 Ischemic Heart Disease: Response to Lee
- 2023511893-1895 Rebuttal to Lee / Katzenstein Commentary on Passive Smoking Risk
- 2023511896-1899 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511900-1906 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response to Criticism
- 2023511908-1911 Deaths From Lung Cancer and Ischemic Heart Disease Due to Passive Smoking in New Zealand
- 2023511912 Deaths From Lung Cancer and Ischemic Heart Disease Due to Passive Smoking in New Zealand
- 2023511913 Passive Smoking in New Zealand
- 2023511914 Passive Smoking in New Zealand
- 2023511915 Passive Smoking in New Zealand
- 2023511916 Passive Smoking and Passive Thinking
- 2023511918-1937 Cardiovascular Diseases and the Work Environment A Critical Review of the Epidemiological Literature on Chemical Factors
- 2023511939-1950 Clinical Progress Series Passive Smoking and Heart Disease Epidemiology, Physiology, and Biochemistry
- 2023511952-1957 Review Passive Smoking and the Risk of Heart Disease
- 2023511958-1961 Aha Medical / Scientific Statement Position Statement Environmental Tobacco Smoke and Cardiovascular Disease A Position Paper From the Council on Cardiopulmonary and Critical Care, American Heart Association
- 2023511965-1983 the Health Consequences of Involuntary Smoking A Report of the Surgeon General
- 2023511985-1998 Environmental Tobacco Smoke Measuring Exposures and Assessing Health Effects
- 2023512000-2015 Environmental Tobacco Smoke Proceedings of the International Symposium at Mcgill University 890000 Environmental Tobacco Smoke and Cardiovascular Disease: A Critique of the Epidemiological Literature and Recommendations for Future Research
- 2023512016-2028 Panel Discussion on Cardiovascular Disease
- 2023512030-2037 Indoor Air Quality and Ventilation Environmental Tobacco Smoke (Ets) and Cardiovascular Disease
- 2023512039-2054 A Critique of the Methods Used to Assess the Toxic Effects on Man of Combustion Products.
- 2023512056-2066 Coronary Heart Disease and Involuntary Smoking
- 2023512068-2077 7. Environmental Tobacco Smoke and Coronary Heart Disease
- 2023512079-2088 Environmental Tobacco Smoke and Coronary Heart Disease
- 2023512090-2091 Editorial Give A Dog-End A Bad Name
- 2023512093-2108 Weaknesses in Recent Risk Assessments of Environmental Tobacco Smoke
- 2023512110-2129 Environmental Tobacco Smoke and Mortality A Detailed Review of Epidemiological Evidence Relating Environmental Tobacco Smoke to the Risk of Cancer, Heart Disease and Other Causes of Death in Adults Who Have Never Smoked - 5 Heart Disease
- 2023512131-2155 Environmental Tobacco Smoke Exposure and Occupational Heart Disease
- 2023512157-2171 Passive Smoking and Coronary Artery Disease. Biological Plausibility and Severity of Effect
- 2023512173-2180 Carbon Monoxide and Cardiovascular Disease: An Analysis of the Weight of Evidence
- 2023512185-2189 the Effects of Passive Inhalation of Cigarette Smoke on Excercise Performance
- 2023512192-2195 Effect of Passive Smoking on Angina Pectoris
- 2023512199-2202
- 2023512203-2213 Effect of 'passive' Smoking on the Physical Load Tolerance of Coronary Heart Disease Patients
- 2023512216-2220 Indoor Passive Smoking: Its Effect on Cardiac Performance
- 2023512223-2224 Passive Smoking Severely Decreases Platelet Sensitivity to Antiaggregatory Prostaglandins
- 2023512227-2230 Platelet Sensitivity to Prostacyclin in Smokers and Non-Smokers
- 2023512233-2237 Besitzen Passivraucher Ein Erhohtes Thromboserisiko?
- 2023512241-2244 Passive Smoking Affects Endothelium and Platelets
- 2023512247-2253 Lipoprotein and Oxygen Transport Alterations in Passive Smoking Preadolescent Children the Mcv Twin Study
- 2023512256-2257 Abstracts of the 30th Annual Conference on Cardiovascular Disease Epidemiology Children's Hdl-Chol: the Effects of Tobacco: Smoking, Smokeless and Parental Smoking
- 2023512261-2266 Passive Smoking Alters Lipid Profiles in Adolescents
- 2023512269-2274 Serum Lipids & Lipoprotein Profiles of Cigarette Smokers & Passive Smokers
- 2023512278-2279 8th Worldconference on Tobacco or Health Building A Tobacco-Free World 920330 - 920403 Buenos Aires - Argentina Abstracts, Posters and Videos. Serum Lipoproteins in Nonsmokers Chronically Exposed to Tobacco Smoke in the Workplace
- 2023512282 the Association Between Carotid Arterial Wall Thickness and Active and Passive Cigarette Smoking
- 2023512285 Passive Smoking and Carotid Artery Wall Thickness: the Aric Study
- 2023512290-2297 Passive Smoking Increases Experimental Atherosclerosis in Cholesterol-Fed Rabbits
- 2023512300-2301 Supplement to Circulation Abstracts From the 65th Scientific Sessions New Orleans Convention Center New Orleans, Louisiana 921116 - 921119
- 2023512304-2307 Association of Passive Smoking with Increased Coronary Heart Disease Risk Is Not Explained by Elevation of Leucocyte Count
- Date Loaded
- 24 May 1999
- UCSF Legacy ID
- shc02a00
Document Images
Adult mortalitv from passive smoking
259
Table A]. Annual U.S. male lung cancer deaths from passive smoking
Rtlative Rtsk ,
Constant at '_.1
Age of
Death Neversmoker
Death'i Rate
per 100.000 ~ Nonsmoker
Population
1000's
Fraction
Exposed Exposed
Populatton
1000's
Excess
Death Rate
Deaths
35-39 1.8 ~ 5156 0.71 3815 1.09 42
40~-44, 2.9 ' 4136 0.72 2980 1.78 53'
45-49 4.5 3477 0.70 2440 2.80 68
iI
50-54,
7.01
3431i
0.66
2260
4.46
101
55-59 11 3423 0.63' 2155 7.15 154
60-63 16, 3489 0.59 2054 10.7 219
65-69 23 3150 0.54 1695 15.9 269
70r74 33 2443 0.45 1099 24.3 _'67'
75-79' 49 1712 0.3' 633, 38.3 24_°'
80i84 72 921, . 0.27 249' 61.1 15''
85 - 95 516 0.08 41 96.0 39
Totals 15.9 31844 0.61 19420 8.26 1606
Appendix A
Derails of death calculations
Tables Al and A2 show the details of the death calculations
for male lung cancer and female cancer other, than lung and
are similar in all respects to Table 6 in the text except thart
no d'eelining relative risk calculation is shown for male lung
cancer since the evidence that was available (Hiravama.
1984a) indicated no suchAecline.
In Table A3 the details are given for the development ofi
the never smoker relative nsks for heart disease that were
use&in the death ~ calculations. As noted in the text. the 1963'
neversmoker heaR' death rates by 5-year intervals were ob-
tained~bv dividing the never smoker coronary heart deaths in
HammondTs (1966) appendix. Table 14, by the person years
in his appendix tables 2a and2b. Reduction factors to account for the change in heart death rates
between 1963 (end ofHammond7s study) and 1984 were then developed by 10:year
age intervals from the age specific heart death rates in table
24 ofiHealth U.S. 1986(NCHS.1986): These reduction factors
were modified for the fractions thought to be due to smoking
which were taken from~a staff report of the Office of Tech-
nology Assessment (OTA. 1985) to yield a combine&never
smoker reduction factor. interpolated back to 5-vear age in-
tervals. for application to the Hammond never smoker death
rates. These modified rates. which are forenrollment age and
therefore about 2 vearsyounger than age of death. were then,
plotted~ agairut age of death on semi.loe graphipaper. Treli
lines were then drawn through the female and the male points
to yield the values in the last column of Table A3.
Tables A4 and A5 are simply the details of the heart death
calculations as in Tables 6. Ali. and'A2'for cancer.
The deaths shown in Table 7 resulting from the corrections
for misclassification were calculated from the relative risks in
lines 4 of Table 5 taken as constant over the age ranee. The
modification of the observed relative risks for smoker mis-
classification as shown in Table 5 are based on misclassified
smoker relative risks calculated as follows. Based on as vet
unpublished work of Wells on misclassification it was assumed
that self-reported current smoker relative risks for male and
female lung cancer in the U.S. and U.K. were 11 and 7. and
4'.6 and 2.7 for male and female current smokers in Japan
Table A2. Annual U.S. female deaths from cancer other than lung from passive smoking.
Exposed Relative Risk
Constant ati 1.16 Relative
Risk
f Neversmoker
D
R Population
T
bl
6
E Declining
Age o
Death eath
ate
per 100.000 a
e
)
(
1000's. xcess
Death Rate
Deaths
RR Deaths
35-39 28 5781 3.9 22.5 4.5 13211 \V
40-44 48 . 425'- 6.7 285 29 14'11 ©
45-49 80 3423 11!.2 383 2 0 1--t9 ~
50-54 125 3355 17.6 589 1.56' 1579
55-59 190 3495 26.8 937 1.30 1591
60-64
265
32-18
37.7
1219
1.18 1352 V1
65-69 355' 2912 5711 1487 1.12 11" ~
70-74: 470 2030 68.7 1395 1.08 729
75-79 600 1472 89 0 1310 1.05 4'?1 ~
80-a4 750 547 114.7 627 1.034 138 ~
8-S* 900 100 14117 142 1.0:21 20
~
Totals 256 30595 28.1 8599 11165 '

260
A 1 %Le11s
Table A3. Development of 1984 neversmoker, heart death rates versus age.
Death rates from
Hammond (1966)
Age at enrolltd age
Range per100.000,
Females:.
1984
1984 wNeversmoker
Decline. Fraction Neversmoker Hammond's heart
in heart of,deciine Death Rate N.S. D.R. death rate
DR's 11 due to as x of1963 corrected by age of
1963-83 smoking (smoothed) for decline death
35-39 71 49 3.5 _'
0!
48 0 .
40-44 14.1 55 7.7 4.4
45-39' 20:.3 ' 60! 12.2 10.2
37 0
50-54 35:5 63 28.7 23
55-59 104 64 66 51
01
60-64 243 64 156 113
65-69 475 64 304 240
37 0
70-731 %f 64 615 480
75-79 1648 65 1072 870
35 0
80183 2774 70 1942 ' 1550
85+ - 21 0 79 - 2770
.Ncles
35-39
T
76
0
20
48 50.
40-44
79:5 77 61 36
45-49 85.5 78 67 68
42 50
50-54 220 77 169 128
55-59 397 75 298 237
37:5 ?5
60 -6s' 741 75 556 412
65-69 1089 76 827 730
32' 25
70-74 1936 76 1472 1150
75-79 2639 77 2021 1850'
25' 10
80-84 a'373'. 81 3343 2950
85+ - 1.4 10. 86 - 3700
(Hi'rayama. 1984a): The 5% of ever smokers who were as-
sumed miscliissified as never smokers were assumedito consist
of 239e light current smokers and 77% long term exsmokers.
The excess risks for currenr, self.reported smokers were re-
duced by 2/3 to yield~ relative risks for misclassified current
smokers an& by 11/12' for relative risks of misclassified
exsmokers essentially as was done by Wald er al: (1986). This
resulted in misclassified ever smoker relative risks of 2.4. and'
1.85 for males and4emales in the U.S. and U.K. and 1.5 and
1.25 for Japan. Worldwide misclassified smoker relative risks
were then calculated to be 1.8 for males and 1.6 for femalesbased on the proportion of "western" and
"eastern" cases.
The false relative risks shown on lines 2 in Table 5 were then
calculated using the formulae in Welis' unpublished work.
For female cancer other than lung. the smoker relative risk
of 1.05 was taken from Hammond (11966) and used as is since
the effect is too small to make any difference. For ischemic
hearr disease the ever smoker relative risks from Hammond'
Table A4. Annual'U. S. female heart deaths from passive smoking.
Relative Risk Relative
Neversmoker Exposed Constant at 1'.23 Risk
Death Rate Population Declining
Age of per 100:000 (Table 6) Excess
Death (Table A3) 1000's D.R. Deaths RR Deaths
35-39 2.0 5781 0.38 22 4.0 91
i0ii.t 4.4 4252 0.84 36 2.0 97' ~
45-49'
50-51 10.0
23 3423
3355 1.91
4.4 65
148 1.32
1.17 85
114
~
55-59' 51 3495 9.8 3" 1.17 :65'
~
60-64 1,13 3238' _2.1 713 1.17 548 .
.~
65-69
70-7.1 240
480 2912
2030 17.7,
97? 1385
1973 1.17
1.17 1062
1505
IiA
75-79 870 1472 180 2647 1.17 2010
80- 8a 1550 517. 33+t 1828 11.17 1374 ' ~
85+ 2700 100 607 607 1.17 J51
~
Totals 291 30595 31.9' 9768' 7602

Adult mortality from passive smoking
Table A5: Annual l' S. male heart deaths from passive smoking
Neversmoker
D
R
Exposed
P Relative Risk
Constant at 1.31 Relative
Risk
f
A eath
ate
000
100 opulation
(Tabl
A1)
E Declining
ge o
Death per
.
(Table A3) e
,
T000's xcess
D.R.
Deaths
RR
Deaths
35-39 20 3815 4.9 187 5.2 780
40-44 36 2980 8.9 265 3.0 879
45-49 68 2440 16.9 41!1 1'.9'- 929
50-54 128 2660 32.11 723' 1.42 951
55-59 237 2155 59.8 1289 1.28 1_'01'.
60-64 412 2051 105 2157 1.28 2009
65-69 730 1695 189 3195 1.28 297.
70-74: 1]50 1099 304 3341 1.28 3103
75-79 1850 633 500 3162 1.28 2933
80-84 2950 249 819 2039' 1.28 1887
85. 4700, 31 1377 565 520
Totals 521 19420 89'3 17335 181t.s
(1966) were taken as 2.3 for, males and 2.0 for females.. The
excess risks were reduced by 2/3 to vield relative risks for
misclassified ever smokers of approximately 1.4 for males and
1.3 for females. These were used worldwide with V4'ells' un-
published formulae to calculate the false heart disease relative
risks shown on lines : of Table 5.
Appendix B
Relatrt.e risks for all'causes of death, and for
emphrsema and chronic obstructive lung disease
Data relating all causes of death with passive smoking for:
females have been reported for four prospective studies to
talltng 9537 cases as shown in Table B 1. The combined relative
risk is 1.165 with 95% confidence limits of 1.11 to 1.22. The
onlv male data available are 75 cases from Gillis et aL (1984))
with a relative risk offl 1.0 so no male analysis was made.
The calculation of the total number of female deaths from
all causes for passive smoking is shown in Table B2. The total.,
3a.1641. is considerably larger than the total for cancer plus
hean of 19.359 shown in Table 7. Some of the difference is
due to uncenainties in the ealculations, but other causes of
261
death that might contribute to the all cause total. based on
data in a pnvate communication from Dr. Htravama. are
cerebrovascular disease, other hean disease. diabetes. and
ulixr.
Hirayama (private communication. also reported preli-
minarilv at 5th World Conference on SmokinQ and Health.
Winnipeg. 1983)provides data relating deaths from emph.-
sema with passive smoking in womem Hisrelativr risk. based
on 106 cases is 1.3 with 95rir confidence limits of 0:85 to'_.05.
Kalandidi'et a!_ (1987) report incidence data for chronic ob
structive lung disease based on 103 cases with an adjusted
relative risk of about 1.4. Lee er aC (',19861 report incidence
data for chronic bronchitis from spouse exposure Based~on
17 cases the adjusted relative risk is 1.22. A,wetehted a%eraee
of these three relative risks would be about 1.3i. The only
neversmoker death rate we have is from Hammond (1966)
for emphysema at 2 x 10-`. Assuming 76 r exposure. the
excess death rate for passive smoking using Eq. (2) would be
0:55 x 10'5 and the total deaths for an.exposed population
of 30.61million would~ be about' 170. Even, if this number iss
doubled to take into account deaths from formsof chronic
far
obstructive lung disease other than emphysema. it u stillT
below the total for cancer and ischemic heart dtsease.
Table BL. Female relative risks for all causes of death from passive smoking.
l All
Exposures Mantel
Trend
Locale Tota
Cases RR 95% C.L. 1tail p
Cohort Studies:
Hiravama (1987)
Japan
9106
1.17
1.12=1.23'
0:(ItKK)1i
Gillis a at.' (198t), Scotland 102 1.45 0.91-2.30
Garland et a!. (1985) California 79 1.06 0.65-1.73'
Vandenbroucke et at. (1983)" Holland 250 0.79 0.57-1.09'
Combined Chon: 9537 1.165
'Dr. Hiravama (private communication):provided the data necessary to calculate these items.,
'Data from 25 vear follow up: Relative risk wasA!89 (0.50-1.62)ifor 1,5 vear follow up. This stud%
is weak
in,that exsmokmg women,were tncluded among the "nonsmokers." and nonsmoking women,exposed to
exsmoker husbands were included in the "nonexposed " The weakness of the study, is emphasized in
that
the smoking women had a lower overall death rate (33.a'~/rYthan thc nonexposed nonsmokers (38, l1:
)_

262
ge
Range Nevetsmoker
Death Rates
(rom Hammond
(19661 at
enrolled age
per T00.000
35-39 136
.t0-4t 178
45-49 254
50-54 352
55-59 561
60-64 867,
65-69 1492
70+-74 2585
75-79 4790
80-8s 8J08
85+ -
A. J Wells
Table B_. Annual US. female deaths from all causes from passive smoking.
Decrement
due to heart
death rate
1963-84
per 100.000
Corrected
Neversrnoker
death rate at
enrolled age
per 100.000
3.6 132.4
6.4 17;1'.6
8.2 245,8
16.8 335:.'
38 523
87 780
171 13211
346 2239
576 4214
832 7576
-- -
Totals
Deaths per million total population
Lee er al: (1986) report data on chronic bronchitis life long
nonsmoking in males exposed,to a smoking spouse. Based on
nine cases the ad)usted relative risk was 0.34. However. for
general' exposure (a' cases) a positive relative risk was ob-
served. No analysis of these data was attempted.
heversmoker:
death rate
t
d
P
l9
io
F Relative Risk
Constant at.1.165
correc
e
to age of death
per 100.000 opu
t
n
exposed
1000's raction
of population
exposed
Excess
D R.
Deaths
120 5781 0,94 17.1 991
155 J'-s, 0.92 21.2 9a-t
212 3323 0;89' 30.5' Ioi-t
300 3355 0.87 43.3 la5'_
445 3495 0.81 6-t15 _254
675 3228 077 98':8 31901
1070 2912 0.70 1583, .1609
1830 2030 0.59 275.2 5596
3250 1472' 0:49' 496.1 7303
6000 547 0:29' 9-t-t.8 5168
10!000' 100 0.10 1623 1623
30595 1]1 7 31]6-t
143
Appendix C
Rate difference mode!'for assessing female ischemic
hearr deaths from passive smoking
A rate difference or absolute risk model was investigated
for female ischemic heart disease in order to compare it to
the relative risk models in ability to translate experience from
one type of culture to another. Female ischemic heart disease
was chosen because considerable data exist and because heart
disease is the largest contributor to total deaths. Also. the
relative risk model seems already to be welCestablished for
lung cancer (Wald ct al:. 1986; Blot and Fraumeni. 1986) so
a comparison~in another disease category appeared to be ap-
propriate.
Data from the four: cohort studies (see Table 4) were com-
bined using the direct pooling equations described on page
183 in Rothman (1986). The two case/control studies were
omitted. Although their combined rate difference was essen-
tially the same as that for the cohort studies, no good way
could be found ao combine it with that from the cohort studies.
Death rates for exposed and not exposed populations were
obtained by dividing the observed deaths in each category by
person years which were equated to the mid-point populations
multiplied'bythe years offoll'owup. The rate difference was
then obtained by subtracting the nonexposed death rate from
the exposed death rate. Vanances and weights were calculated
by Rothman's formulae., The combined rate difference was
obtained by summing the weighted rate differences and di-
viding by the sum of the weights. Confidence limits (95%):
were equated',to the rate difference =1.96 (variance)°=.
The results of these calculations are summarizcd'in Table
Cl. The cohort data were also combined using Program 7 of
Rothman and Boice (1982) ,', with results essentiallv,idemical
to those shown in Table C1 for direct pooling. The relative
heterogeneity of the relative nsks ('RR) vs.,the rate differences
(RD) can be approximated; by considering the range of RR-
1 versus the range of RD: The range of RR-1 is from 0;16 to
2.6 for a factor of. 163. The range of~ the rate differences is
3.7 to 262 'or a factor of 71. The ratio for the two large studies,
Helsingeral: (1988) land Hiravama (1984b), for RR-I': is 0:2d"
0.16 = 1.5 and for RD is 20.7/3.7 = 5.6. The 95"c confidence
limits for the rate ratio combination is tighter than for the
rate difference combination_ ,#lso, the Hiravama study dom-
inates the rate difference aggregation muchlmore than inithe
rate ratio aggregation. providing 64% of the combined weight
(last column of Table Cl) in the rate difference case vs. only
17 0 of the combined weight in the rate ratio case.
Table C1. Rate difference c alculations for fe male i schemic heart disease.
T Relative Risk
from Table 3. Rate difference
x 10''
Wn¢hts
fo
RD ~
RD x ~
h
otal
Cases
RR
95% C.L.
RD
95Pr C.L. r
x 10-" weig
t
x 10- yN~'
Cohort Studies:
Hirayama (d98sb)
394
1.16
0.9- 1.4
3.7
-2.1- 9.6
11110
41 a
Gillis er al. (19fi3) : 21 3.6 0.9-13'.8 169.1 30.7-307.6 2 31
Garlan&er al. (1985) 19 3.5 0;9-13,6 262.2 36.0-188.4 0 & 2.0
Hetsin¢ n a!: (19681 988 1.25' 1.1- 1.4 :0:7 -0.2- 41.6 88 IR.2
Combined Cohort 1522' 1.23 1.1- l.l 5 1 -0:2- 11.1 1201 65 0
~

Adult mortality from passive smoking
Table D1. Regionaliparticle deposition from mouth breathing of side stream smoke
Fraction of inhaled
Aero- Relative particle mass deposued`
dvrta
i V
l M
m
c
diameter
Cube of
Relative o
ume
(Weight) ass
Distribution
mouth trachro
µm diameter eonantration' per 0.liam , 'ii throat, bronchial alveolar
263
F1ass
deposited as
r~ of totall
mass inhaled'
0.20 .008'. 1.5 0.006 0.3 0 0 0.13 0.0a
0.25 .016 6.5 0.051 2.4' 0 0 0.1?' 0:29
0.30 .0.7 10I0, 0.135 6A 0 0 0.115 0:74
0.35 .043 13:0 0:280 13.2 0 0 0.108 1 43
0 40 .064 13.01 0;i 16 19.6 0' 0 0.10 1.96
0.45 .091 6.5 0;296 14.0 0! 0 0.105 1.41
0.50 .125 3.5 032S 15.5 01 0 0.11 1.71
0.60 .216 1.25 0.270 12.7 0 0 0.115 1 .4b.
0.70 .343 0.5' 0.17~_ 8.1'. 0 0 0.12 0.97
0.80 .51L 0.25 0.128 6.0 0 0 0.13 0_78
0:90 .729 0.05 0.036 1.7 0 0 0.14 0.24
1.00 1.0 0 0 0 0 0 0.15 0(K)
:.1!18 99.9 11.08
From Hiller rr a!. (19821. Fig. 1.,
'From ~Hevder (1984).,Table 1. 250 cm'fsecond mean flo%% ' rate. 4 second breathing cvcle.
This domination of the rate difference model by the Jap
anese study is evident from some rouch death calculations.
Use of the combined rate difference (5;a x 10") with the
exposed female population from Table A4: (30.6 million))
yields total deaths of L6fi2 compared with 9.768 calculate&
from the constant rate ratio modell VJhen the rate differences
are plotted against age of death~and weighted accordinglv it
is found that the "westertr " rate differences increase sharply
with age whereas the Japanese rate difference stays constant
at about 4 x 10'. Constructing a weighted average of these
western-' and ' eastern" death rates for each of the 5 vear
age ranges and multiplying h} the corresponding exposed pop-
ulations yields a total of about 2.100 deaths compared with
7.602 in the second relative risk modell Use of the Japanese
data alone vield's about 1.200 deaths. Use of oniv the "west-
ern" data (Gillis er al.. 1994: ',Garland ei . al.. 1988: Helsing
ett al: ) at a constant, rate difference yields 7,950~deaths while
use of "western~' data with the rate difference vanine with
age yield5 about 30.000 deaths. Thus. the death caltulations
using rate differences are quite vofatile, Also. it is evidentt
that with the rate differences it is not feasible to carrn- over
the "eastern° experience. in ischemic hearr disease at
least, for use in a"western" setting.. Accordmglt. it' was
concluded that the absolute risk model' is not as suited to
combining risks for passive smoking asthe relative risk
models.
Table D3: Regional ~ particle deposition from nose breathing of sidestream smoke.
Aero-
i
Fraction of inhaled
particle mass deposited" Mass deposited as
K
of total mass
dynam
c Mass
diameter distribution
mouth
ttachco- inhaled
µm % . nose throat bronchiai alveolar nose alveolar
0:20 0:3 0 0 0 0.19 0.00 0.06
0125 2.4 0.005 0 0 0.172 0.01 0.41
030 6.4 0.01 0 0 0.155 0.06 0.99
0.35 13.2 0.015 0 0 0.13R 0.20 1.82
040 19.6 0.02 0 0 0.12 0.39 2.35
0.45 14.0 0.03' 0 0 0.11-2 0.42 1.70 ~
0.50 15.5 0.04 0 0 0.125 0.62 1.94
0.60 12.7 0.05 0 0 0.1_R 0;6,t 163
0.70 8.11 0.06 0 0 0.13 0.49 1 05
0
80 6
0 077
0 0 0 0:13; 0!46 (1!Rn',
L
.
0.90 .
1.7 .
0.093 0 0 0:137 0!16 0;23 #"
1.00 0.0 0.11 0 0 0:1a 0.(10 0,(uiI ~
3.45 1'_.99
°From Table D1!. ~
"From Hevden(1984). Table 2. 250 cm',second'mean.OoM rate. .4 secondbreathtng cycle..

264
A J MctIA
Table D3. Smoke Particle deposition patterns in direct and passive smoking
Direct Smokintt Passive Smoking Direm, Passisc
Entry site
Particulate inhaled per day. me. Mouth
:a0 tiose
2.8
86
Particle Size inhaled. µm 0 7 0.4
Particle size exhaled.,µm 07 04
Retained in nose, 5r 0 3.5
Retained in mouth. i7', 25 0
Retained in tracheerbronchial reaion. % 35 0
Retained in near alveolar reeion_ % 19 0
Retained in deep alveolarregion. 4c 9 13
Totallretained. °k 90 16.5
Particulate retained. total. mg. 192, 046 177
Particulate retained. alveolar. mg. 48 0.36 133
Particulate retained. deep alveolar. mg. 2-1 0.36 61
Appendix D
Dose considerarions
As noted in the text. there is a wide difference between
the observed'disease ratio between passive and active smokers
and the ratio of cigarette smoke particulate retained by, each.
Also, the cancer sites appear to differ. On the assumption
that part of these differences may be due to differences in
deposition sites between passive smoking and active smoking,
calculations were carried out to try to pinpoint these differ-
ences.
The calt:ulations for passive smoking are reasonably
straightforward. Stober (1984) has summarized all the uncer-
tainties in this type of calculation. Nevertheless, the best ap-
proa& appears to be to use the data of Hiller et al. (1982)
for the particle size range of side stream smoke, centering
around 0:4 µm, and the mathematical lung modellof Heyder
(1983), for inert particles. Integration of these two data sets
yields a distribution of deposited weights by particle size for
mouth breathing (see Table D1) which. when summed: vields
exactlv the total': deposition observed by Hiller et al:. (1982)
indicating that the Heyder modeliholds for passive smoking.
The same inhaled particle size distribution camthenbe applied
to Hevder's nose breathing case (see Table D2) which yields
nasal deposition of 3.5c%e and deposition in the alveolar region
of the lUng of 13:04c. The model predicts zero deposition for
both the mouth,throat and the tracheo-bronchial regions.
From the depositiomcurves of Gerrity er aG (1979) (Fig. 2)
for iron oxide extrapolated to a particle size of 0.25 µm.(which
is eq uivalent to an aerodynamic diameter of 0.4 µm ) it appears
that all of the lung deposition from passive smoking probably
occurs deep in the alveolar region at generation 19 or beyond.
Black and Pritchard (1984) have determined the half-time for
alveolar retention for direct cigarette smoke to be 17 hours
indicating that the smoke particles dissolve and clear into the
blood or lymph system. There is every reason to believe that
the passive smoke particles clear the same way.
With direct smoking there has so far been no model de-
veloped'that explains the observed phenomena, namely that
the inhaled particle size is about 0.7' µm, that 70% to 809c
of the inhaled smoke is retained, that 15 to 359'e is retained
in the mouth, and that the exhaled~panicle size is also about
0.7 µm; The Heyder modeli at 0l7 µm, would predict total
retentiomof only 12%. To achieve 75% retention, the Heyder
model would require an effective particle size of 6.5 µm, Main
streamismoke is knowmto agglomerate. but if it agglomerated
to 6.5 µm, the exhaled' smoke. according to the He.der
modeli, would be about 6 µm, much too, large compared to
that observed. Mitchell (1962) observed that direct smoke
particles grow in the mouth to about 1.15~µmi and that the
smoke exhaled from the lung after a S second retention period
had a mass median diameter size of 0.65 µm. Let us assume
that the 0.65 µm part of'the smoke follows Hevder's model
an&thar209c of the total smoke inhaled was exhaled', all from
the 0;65 µm fraction. The inhaled part of the smoke corre-
sponding with the 0.65 µm part exhaled would have the same
particle size and would deposit about 12%. deep in the al-
veolar region.. This is 1'217c of 22.7ro of the total smoke in-
haled'~ or 2.7% of the total inhaled smoke. The balance of
the inhaled smoke (77%) would have a larger average particle
sizeabout 1.3 µm. Black and Pritchard (198-1)lfound. based
on clearance data, thatthe rates of alveolar c+eposition to
alveolar plus tracheo-bronchial deposition, in, direct smoking
is 0.36. Also, as noted, some amount, say 25% of the total
inlet smoke should deposit in the mouth and throat. all of
which would have to come from thislarger size fraction.,Sum-
marizing these numbers, of the 100 -'0 -'5 = 55cc of
total smoke particulate that reaches the lun¢ and is non ex-
haled, 0~64 x 55, = 35% deposits in the tracheobronchial
region and 0.3& x 55 = 20% deposits in the alveolar region,
We have already accounted for 3% of the alveolar deposition
from the 0:65 µm particles. The remaining 17% would come
from the largerparticles.,Based on the alveolar/tracheo-bron-
chial split and using the curves of Gerrity er al: (1979) it would
be expected that about 2/3 of the alveolar deposit or l1,rr,
would deposit in the "near° alveolar region, generations 16-
18, and 6% in the "deep" alveolar region., generations 19-
21, for a total "deep" alveolar deposition of 9%. These cal-
culations are summarized in Table D3.
Just what the mechanisms are for so much direct smoke
deposition remains unclear. Certainly impaction and sedi-
mentatiom(thc Heyder model) do not account for it. Stober
(196-t)isuggests that electricallcharges in the newly generated
smoke particles (see Melandri er al:, 1983) mav aceounv for
some of it. Another possible mechanism is the cloud settling
phenomenon as described by Fuchs(196J).
Whatever the mechanism, a reasonably clear idea of the
regionalI deposition patterns from direct and passive smoking

Adult mortalirkfnm passne smoking
can be obtained as shown in Table D3. The nasal deposition
from passive smoking could account for the observed nasal
sinus cancer. Also. if the observation of Balin er aL (1986) is
correct that there is a direct passage for toxics from the nose
to~ the brain, it could also account for the observed brainn
cancer. Ih the deep alveolar region the ratio of direet to pas-
:h`
sive deposition is much closer to the inhaled'ratio ~than to the
"total retained" ratio. It is from the deep alveolar region thac
the smoke particles are solubilized and clearedGnto the blbo&
and lymph systems possibly to cause cancers of the liver,
breast and endocrine glands, leukemia. hmphoma and ar-
terial plaques.
